Daridorexant is a dual orexin receptor antagonist being developed by Nxera for the treatment of adult patients with insomnia and is approved and marketed in Japan as QUVIVIQ®Phase 3 trial of daridorex ...
At CES 2026, the world's most influential technology event, Leopard Imaging Inc. showcased its full portfolio of AI vision solutions, demonstrating ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback